(Q40991772)

25 September 2017

1 reference

title

The renin-angiotensin system in left ventricular remodeling (English)

1 reference

25 September 2017

Blaufarb IS

1

1 reference

25 September 2017

Sonnenblick EH

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Cardiology

25 September 2017

published in

1 reference

25 September 2017

volume

77

1 reference

25 September 2017

issue

13

1 reference

25 September 2017

page(s)

8C-16C

1 reference

Global cardiac remodeling after acute myocardial infarction: a study in the rat model

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Cellular basis of chronic ventricular remodeling after myocardial infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

A Hemodynamic Study of Left Ventricular Aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Geometric and muscle physiological determinants of cardiac stroke volume as evaluated on the basis of model calculations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Late ventricular dilatation in survivors of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Patterns of left ventricular dilation during the six months after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: Time course and hemodynamic consequences at rest and during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Infarct expansion versus extension: two different complications of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Cellular mechanisms of myocardial infarct expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Topographic changes in the left ventricle after experimentally induced myocardial infarction in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Stretch-induced programmed myocyte cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

The histopathologic evolution of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Two-dimensional echocardiographic recognition of myocardial injury in man: comparison with postmortem studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Increased afterload aggravates infarct expansion after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: a two-dimensional echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. Incidence, natural history, and prognostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Predicted effect of chronic apical aneurysms on the passive stiffness of the human left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Serial changes in left ventricular size after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Wall stress and patterns of hypertrophy in the human left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Angiotensin II: hemodynamic regulator or growth factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Attenuation by prostaglandins of the facilitatory effect of angiotensin II at adrenergic prejunctional sites in the isolated Krebs-perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Suppressive effect of captopril on platelet aggregation in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Is aspirin safe for patients with heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Role of Bradykinin in Hypertension and the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Kinins mediate the antiproliferative effect of ramipril in rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

A new highly potent antagonist of bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

The bradykinin-induced coronary vasodilation. evidence for an additional prostacyclin-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Pericardial release of prostacyclin induced by bradykinin and angiotensin II: effects on coronary blood flow in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Kinins and Endothelium-Dependent Relaxations to Converting Enzyme Inhibitors in Perfused Canine Arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Hemodynamic Effects of Direct Angiotensin II Blockade Compared to Converting Enzyme Inhibition in Rat Model of Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Tissue angiotensin II system in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Converting enzyme inhibition in isolated porcine resistance artery potentiates bradykinin relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Peripheral hemodynamic effects of captopril in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Regulatory functions of the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900183-X

10.1016/S0002-9149(96)00183-X

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference